Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GC Medical Science ("Green Cross Medical Science", "GCMS") is an active Korean life science company specializing in the development and manufacture of advanced diagnostic reagents and kits—primarily focused on infectious diseases such as HIV/AIDS and tuberculosis—with global regulatory approvals. Originally founded within Green Cross Corporation's blood typing business line in the early '70s before being spun out into an independent entity by its parent group ("GC Pharma"/"Green Cross") in 2004. The company's product portfolio exceeds over two hundred fifty different assays covering nearly forty indications/disease areas worldwide—including notable innovations like Korea’s first AIDS test kit—and it maintains significant international partnerships/distribution channels while continuing R&D into next-generation molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GC Medical Science.